Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Regulation of Regional Lipolysis
NCT06392854Phase 1Recruiting
- Sponsor
- Mayo Clinic
- Start
- May 2024
- Primary completion
- Jun 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of human insulin in obesity (2 arms), sponsored by Mayo Clinic. Primary endpoint: Palmitate release at 6 hours. Started May 2024; status: recruiting.
02
Drugs
human insulin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06392854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06392854.